NACDS’ Anderson: Pharmacies’ trust ‘shines through again’ with ACA
ALEXANDRIA, Va. — “Pharmacies’ efforts to help patients understand aspects of the Patient Protection and Affordable Care Act are demonstrating yet again the value of pharmacies as the face of neighborhood healthcare.” That was a key message that National Association of Chain Drug Stores president and CEO Steve Anderson expressed in a recent opinion piece.
In the piece, dated Sept. 13, Anderson discusses how pharmacies are being responsive to patients who are asking questions about what the Affordable Care Act means for them. Recognizing the trust that patients place in their pharmacies with regard to the implementation of the Affordable Care Act, chain pharmacies are helping patients understand the law.
“In the implementation of both the ACA (enacted with a Democratic president in the White House) and Medicare Part D (enacted with a Republican president in the White House), pharmacies did what they have done for generations — served as a trusted resource for the patients they serve,” Anderson wrote.
To read the entire opinion piece, click here.
Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.
Acetaminophen Awareness Coalition warns against APAP overdose as cold-flu season approaches
WASHINGTON — The Acetaminophen Awareness Coalition last week issued their annual call for consumers to "Double Check, Don’t Double Up" their cold medicines for acetaminophen content in an effort to avoid accidental overdose.
Acetaminophen is found in more than 600 different medicines, the Coalition noted. Taking more than directed is an overdose and can lead to liver damage.
Members of the AAC include the Alliance for Aging Research, National Association of Boards of Pharmacy, American Association of Nurse Practitioners, National Association of Chain Drug Stores Foundation, American Academy of Physicians Assistants, National Community Pharmacists Association, National Consumers League, American Pharmacists Association, National Council on Patient Information and Education and CHPA Educational Foundation.
FDA approves first generic version of Genentech chemotherapy pill
SILVER SPRING, Md. — The Food and Drug Administration has approved a generic chemotherapy pill for treating colorectal and breast cancers, the agency said Monday.
The FDA announced the approval of Teva Pharmaceutical Industries’ capecitabine tablets in the 150-mg and 500-mg strengths. The drug is used to treat cancers that have metastasized, meaning they’ve spread to other parts of the body.
The drug is a generic version of Xeloda, made by Roche division Genentech. According to IMS Health, Xeloda had sales of $706.2 million last year.